title: [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
authors.affiliation: Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Hangzhou 310014, China. ydh-11@163.com
authors.forename: Dan-hong
authors.initials: DH
authors.lastname: Yang
authors.forename: Shi-feng
authors.initials: SF
authors.lastname: Xie
authors.forename: Ying-min
authors.initials: YM
authors.lastname: Wang
authors.forename: Nian-feng
authors.initials: NF
authors.lastname: Zhao
authors.forename: Min-wei
authors.initials: MW
authors.lastname: Li
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000821:virology*; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D063065:Organophosphonates; D019259:Lamivudine; D000225:Adenine; C106812:adefovir dipivoxil